Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Barbara White?

Barbara J. White

Chief Medical Officer

Corbus Pharmaceuticals Holdings, Inc.

HQ Phone:  (617) 963-0100

Direct Phone: (617) ***-****direct phone

Email: b***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Corbus Pharmaceuticals Holdings, Inc.

100 River Ridge Drive

Norwood, Massachusetts,02062

United States

Company Description

Corbus Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases. Our lead product candidate, Resunab™ ... more.

Find other employees at this company (39)

Background Information

Employment History

Senior Director

MedImmune , Inc.


Roles

Amgen Inc.


Vice President, Clinical Development

Aviron


Professor of Medicine and Vice Chair for Research, Department of Medicine

University of Maryland


Co-Director

Johns Hopkins University


Senior Vice President and Head of Research and Development

Stiefel Laboratories , Inc.


Roles

UCB S.A


Affiliations

HOA

Board Member


American College of Rheumatology

Board Member


Food and Drug Administration

Ad Hoc Member of the Arthritis Advisory Committee


Education

University of Maryland


MD


medical degree

University of Pennsylvania School of Medicine


Web References(91 Total References)


Overview :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD
Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and View Full Bio


Management Team :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD
Barbara White, MD Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and dermatology diseases. She also has industry experience in pre-clinical drug development, translational medicine and medical affairs. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. She has held roles at UCB, MedImmune and Amgen. Prior to her pharmaceutical career, Dr. White was professor of medicine and Vice Chair for Research, Department of Medicine, at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. She also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.


Form 10-K

ir.corbuspharma.com [cached]

In addition, the loss of the services of certain key employees, including Yuval Cohen, our CEO, Mark Tepper, our President and Chief Scientific Officer, Barbara White, our Chief Medical Officer and Sean Moran, our Chief Financial Officer would adversely impact our business prospects.
In particular, we believe that the loss of the services of Yuval Cohen Ph.D., our Chief Executive Officer, Mark Tepper Ph.D., our President and Chief Scientific Officer, Barbara White, M.D., our Chief Medical Officer and Sean Moran, C.P.A., M.B.A., our Chief Financial Officer, would have a material adverse effect on our business.


www.sec.gov


0001625844 White Barbara C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062 0 1 0 0 Chief Medical Officer


ir.corbuspharma.com

"There are no approved treatments for inflammation in CF, which is the major cause of lung damage in individuals with CF," added Barbara White, M.D., Chief Medical Officer of the Company.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory